Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Cash & Current Investments of $143.0 million for Q1 2026, up 39.92% year-over-year from $102.2 million in Q1 2025, and down 13.14% quarter-over-quarter from $164.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash & Current Investments data on file, last reported at $143.0 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $143.0 million, up 39.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $143.0 million (up 39.92% YoY), and the FY2025 annual result was $164.6 million, up 54.63% from the prior year.
- Cash & Current Investments retreated to $143.0 million in Q1 2026 per STVN's latest filing, from $164.6 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $411.6 million in Q1 2022 and troughed at $64.3 million in Q2 2023.
- A 5-year average of $167.2 million and a median of $141.6 million in 2025 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 1066330.2% in 2022, then slumped 80.9% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $267.7 million in 2022, then tumbled by 70.25% to $79.6 million in 2023, then surged by 33.67% to $106.4 million in 2024, then surged by 54.63% to $164.6 million in 2025, then declined by 13.14% to $143.0 million in 2026.
- Business Quant data shows STVN's Cash & Current Investments at $143.0 million in Q1 2026, $164.6 million in Q4 2025, and $141.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 142.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.95 Mn |
| Dec 31, 2025 | 164.57 Mn |
| Sep 30, 2025 | 141.56 Mn |
| Jun 30, 2025 | 120.76 Mn |
| Mar 31, 2025 | 102.16 Mn |
| Dec 31, 2024 | 106.43 Mn |
| Sep 30, 2024 | 88.56 Mn |
| Jun 30, 2024 | 86.65 Mn |
| Mar 31, 2024 | 206.04 Mn |
| Dec 31, 2023 | 79.62 Mn |
| Sep 30, 2023 | 68.21 Mn |
| Jun 30, 2023 | 64.27 Mn |
| Mar 31, 2023 | 191.93 Mn |
| Dec 31, 2022 | 267.65 Mn |
| Sep 30, 2022 | 262.34 Mn |
| Jun 30, 2022 | 336.48 Mn |
| Mar 31, 2022 | 411.56 Mn |
| Dec 31, 2021 | 501.33 Mn |
| Sep 30, 2021 | 504.01 Mn |
| Jun 30, 2021 | 120.70 Mn |